Search Results - Adrian G. Sacher
- Showing 1 - 12 results of 12
-
1
-
2
Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study by Rossanna C Pezo, April A N Rose, Cristiano Ferrario, Mengqi Li, Soumaya Labidi, Nicholas Meti, Reeta Barua, Jamila Riromar, Di Maria Jiang, Nazanin Fallah-Rad, Srikala S Sridhar, Sonia V Del Rincon, Susanna Cheng, Adrian G Sacher
Published 2024-03-01
Article -
3
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer—A Single-Center Experience by Shelley Kuang, Kaitlin Chen, Sachin Sayal, Gajeni Prabahan, Mary R. Rabey, Lisa W. Le, Andrew Seto, Frances A. Shepherd, Geoffrey Liu, Penelope Bradbury, Adrian G. Sacher, Jennifer H. Law, Peter Sabatini, Tracy L. Stockley, Ming S. Tsao, Natasha B. Leighl
Published 2024-08-01
Article -
4
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study. by Esmail M Al-Ezzi, Zachary W Veitch, Samer H Salah, Theodorus H Van der Kwast, Tracy L Stockley, Shamini Selvarajah, Tong Zhang, Srikala S Sridhar, Adrian G Sacher, Nazanin Fallah-Rad, Girish S Kulkarni, Alexandre R Zlotta, Antonio Finelli, Aaron R Hansen
Published 2021-01-01
Article -
5
Outcomes with non-small cell lung cancer and brain-only metastasis by Sabine Schmid, Miguel Garcia, Luna Zhan, Sierra Cheng, Khaleeq Khan, Maisha Chowdhury, Amir Sabouhanian, Joshua Herman, Preet Walia, Evan Strom, M. Catherine Brown, Devalben Patel, Wei Xu, Frances A. Shepherd, Adrian G. Sacher, Natasha B. Leighl, Penelope A. Bradbury, Geoffrey Liu, David Shultz
Published 2024-09-01
Article -
6
Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration‐resistant prostate cancer treated with Radium‐223 by Esmail M. Al‐Ezzi, Husam A. Alqaisi, Marco A. J. Iafolla, Lisa Wang, Srikala S. Sridhar, Adrian G. Sacher, Nazanin Fallah‐Rad, Di M. Jiang, Geoffrey A. Watson, Charles N. Catton, Padraig R. Warde, Rob J. Hamilton, Neil E. Fleshner, Alexandre R. Zlotta, Aaron R. Hansen
Published 2021-09-01
Article -
7
Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence by Niki Esfahanian, Sze Wah Samuel Chan, Luna J. Zhan, M.Catherine Brown, Khaleeq Khan, Jae Lee, Karmugi Balaratnam, Elizabeth Yan, Jennifer Parker, Miguel Garcia-Pardo, Samir H. Barghout, Lawson Eng, Penelope A. Bradbury, Frances A. Shepherd, Natasha B. Leighl, Adrian G. Sacher, Stephanie Snow, Rosalyn Juergens, Geoffrey Liu
Published 2023-01-01
Article -
8
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer by Shelley Kuang, Andrea S. Fung, Kirstin A. Perdrizet, Kaitlin Chen, Janice J. N. Li, Lisa W. Le, Michael Cabanero, Ola Abu Al Karsaneh, Ming S. Tsao, Josh Morganstein, Laura Ranich, Adam C. Smith, Cuihong Wei, Carol Cheung, Frances A. Shepherd, Geoffrey Liu, Penelope Bradbury, Prodipto Pal, Joerg Schwock, Adrian G. Sacher, Jennifer H. Law, Tracy L. Stockley, Natasha B. Leighl
Published 2022-06-01
Article -
9
Integrating comprehensive genomic sequencing of non-small cell lung cancer into a public healthcare system by Kirstin Perdrizet, Tracy L. Stockley, Jennifer H. Law, Adam Smith, Tong Zhang, Roxanne Fernandes, Muqdas Shabir, Peter Sabatini, Nadia Al Youssef, Christine Ishu, Janice JN Li, Ming-Sound Tsao, Prodipto Pal, Michael Cabanero, Joerg Schwock, Hyang Mi Ko, Scott Boerner, Heather Ruff, Frances A. Shepherd, Penelope A. Bradbury, Geoffrey Liu, Adrian G. Sacher, Natasha B. Leighl
Published 2022-01-01
Article -
10
Programmed Cell Death Protein 1 Inhibitors and MET Targeted Therapies in NSCLC With MET Exon 14 Skipping Mutations: Efficacy and Toxicity as Sequential Therapies by Sally C.M. Lau, MD, MPH, Kirstin Perdrizet, MD, Andrea S. Fung, MD, PhD, Danilo Giffoni M.M. Mata, MD, Jessica Weiss, PhD, Nick Holzapfel, MD, Geoffrey Liu, MD, Penelope A. Bradbury, MD, Frances A. Shepherd, MD, Adrian G. Sacher, MD, MMSc, Harriet Feilotter, MD, Brandon Sheffield, MD, David Hwang, MD, Ming Sound Tsao, MD, Susanna Cheng, MD, Parneet Cheema, MD, Natasha B. Leighl, MD, MMSc
Published 2023-10-01
Article -
11
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared... by Ross Andrew Soo, Mark Doherty, Arjun Sahgal, Ai Peng Tan, Mei Chin Lim, Benjamin J Solomon, Kristy P Robledo, Yu Yang Soon, Chee Khoon Lee, Mark B Pinkham, Fiona Hegi-Johnson, Shilo Lefresne, Cheryl Ho, Adrian G Sacher, Alan Nichol, Ambika Parmar, David B Shultz, Ivan WK Tham, Jeremy Tey, Cheng Nang Leong, Wee Yao Koh, Yiqing Huang, Yvonne Li En Ang, Jiali Low, Clement Yong
Published 2024-07-01
Article -
12
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy by Sally C.M. Lau, MD, MPH, Malcolm Ryan, BSc, Jessica Weiss, PhD, Aline Fusco Fares, MD, Miguel Garcia, MD, Sabine Schmid, MD, Shelley Kuang, MD, Deirdre Kelly, MB BCh BAO, Ming Sound Tsao, MD, Penelope A. Bradbury, MB BCh, Byoung Chun J. Cho, MD, Alexander Sun, MD, Srinivas Raman, MD, Andrew Hope, MD, Meredith Giuliani, MBBS, MEd, PhD, Benjamin H. Lok, MD, PhD, Andrea Bezjak, MD, Geoffrey Liu, MD, MSc, Natasha B. Leighl, MD, MSc, Frances A. Shepherd, MD, Adrian G. Sacher, MD, MMSc
Published 2021-12-01
Article